<DOC>
	<DOCNO>NCT01013441</DOCNO>
	<brief_summary>The purpose research study test whether give T-cells ( type white blood cell also know immune cell ) specially process laboratory help chronic lymphocytic leukemia ( CLL ) patient ' immune system return normal fast chemotherapy . This research study also look ability lab process T-cells infusion side effect give T-cells patient chronic lymphocytic leukemia ( CLL ) .</brief_summary>
	<brief_title>CD3/CD28 Bead Activated T-Cells Following Chemo-Immunotherapy Patients With Chronic Lymphocytic Leukemia</brief_title>
	<detailed_description>Single arm , multi-center trial evaluate efficacy administer CD3/CD28 stimulate T cell chronic lymphocytic leukemia ( CLL ) patient follow treatment fludarabine alemtuzumab base chemo- immunotherapy . All patient undergo apheresis collect peripheral blood mononuclear cell ( PBMCs ) generation expand T cell post- chemo-immunotherapy . Those subject achieve complete partial response chemoimmunotherapy base regimen receive infusion 1.0 x 1010 ( +/- 20 % ) activate autologous T cell expand collected apheresis unit . Prior T-cell infusion , Day +30 , +60 , +365 T cell infusion , blood draw perform assess immune reconstitution immune function compare baseline .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<criteria>Diagnosis CLL immunophenotyping flow cytometry analysis blood bone marrow . Patients Rai stage IIIIV OR Patients Rai stage 0II Zubrod performance status 03 Prior treatment fludarabine alemtuzumab base regimen . No untreated uncontrolled lifethreatening infection Women childbearing potential must negative serum pregnancy test agree use medically accept form contraception time initial screen completion study No active CNS disease Negative test HIV antibody , Hepatitis B surface antigen , hepatitis C antibody . Receipt glucocorticoid ( exception inhale glucocorticoid steroid use allergic rhinitis pulmonary disease ) within 2 month prior registration History autoimmune disease unrelated CLL ( e.g. , rheumatoid arthritis , multiple sclerosis , systemic lupus erythematosis ) . Autoimmune disease relate CLL , e.g . idiopathic thrombocytopenic purpura ( ITP ) autoimmune hemolytic anemia , permit require active treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Chronic Lymphocytic Leukemia</keyword>
</DOC>